2020
DOI: 10.1016/j.ccr.2020.213339
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in the chemistry of iron-based chemotherapeutic agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
59
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 83 publications
(59 citation statements)
references
References 178 publications
0
59
0
Order By: Relevance
“…[4] In principle, iron is a convenient choice, since it is a bioavailable element and nontoxic in many forms; [5] moreover, its earth abundancy has made several cost-effective compounds available to the researchers for the exploration of the reactivity and the consequent development of new structural motifs. A variety of mono-iron compounds has been investigated for the anticancer potential, [6,7] and substituted ferrocenes (ferrocifens) have been regarded as promising drug candidates. [8] The feasible Fe + II to Fe + III oxidation in the physiological environment and the conjugation of suitable organic moieties to the robust sandwich scaffold are responsible for a considerable activity, which is basically related to the production of damaging metabolites within cancer cells.…”
Section: Introductionmentioning
confidence: 99%
“…[4] In principle, iron is a convenient choice, since it is a bioavailable element and nontoxic in many forms; [5] moreover, its earth abundancy has made several cost-effective compounds available to the researchers for the exploration of the reactivity and the consequent development of new structural motifs. A variety of mono-iron compounds has been investigated for the anticancer potential, [6,7] and substituted ferrocenes (ferrocifens) have been regarded as promising drug candidates. [8] The feasible Fe + II to Fe + III oxidation in the physiological environment and the conjugation of suitable organic moieties to the robust sandwich scaffold are responsible for a considerable activity, which is basically related to the production of damaging metabolites within cancer cells.…”
Section: Introductionmentioning
confidence: 99%
“…Iron is an attractive element in this respect due to its bioavailability, which substantially limits the toxic effects of its compounds, and the feasible redox chemistry in physiological media, usually involving the +II and +III oxidation states [ 17 , 18 ]. A variety of monoiron complexes have been assessed for the anticancer potential both in vitro and in vivo [ 19 , 20 , 21 , 22 ]. Following the successful experience with ferroquine, a conjugate between ferrocene and the drug chloroquine, which entered phase II clinical trials as an antimalarial agent ( Figure 1 , structure I ) [ 4 , 23 , 24 ], the anticancer properties of related ferrocene derivatives have been intensively investigated (an example in Figure 1 , structure II ) [ 25 , 26 , 27 , 28 ].…”
Section: Introductionmentioning
confidence: 99%
“…Subsequent deprotonation, a second oxidation to generate a ferrocenyl-stabilized carbocation, and a final deprotonation, allows the iron to regain its initial +2 state; the resulting quinone methide is a new bioorganometallic entity that behaves as a selective electrophile. The redox potential of the iron is particularly suitable for biology [89,90], such that on cancer cells the ferrocifens initially produce Reactive Oxygen Species (ROS) that unlock the above-mentioned sequence of reactions. Moreover, the ability of the OM-QM to undergo nucleophilic addition of cellular thiols or selenols, that normally control oxidative stress, plays a crucial role in its bioactivity.…”
Section: Discussionmentioning
confidence: 99%